actuarial survival analyses based on cardiovascular deaths ( average follow-up 3.5 years ) indicate improved survival for the entire surgical matched pair cohort ( p = 0.008 ) and for the surgically treated subgroup with two-vessel disease ( p = 0.0002 ) when compared to the medical cohort .
C0007226
cardiovascular
C0581375
two-vessel disease